UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 357

Sortiert nach

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

European urology, 2018-04, Vol.73 (4), p.543-557

2018

Volltextzugriff (PDF)

Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2299-2305

2017

Volltextzugriff (PDF)

The use of intravesical BCG in urothelial carcinoma of the bladder

Ecancermedicalscience, 2019-02, Vol.13, p.905-905

2019

Volltextzugriff (PDF)

Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review

European urology, 2013-09, Vol.64 (3), p.421-430

2013

Volltextzugriff (PDF)

Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men

JNCI : Journal of the National Cancer Institute, 2013-07, Vol.105 (14), p.1050-1058

2013

Volltextzugriff (PDF)

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

European urology, 2009-09, Vol.56 (3), p.430-442

2009

Volltextzugriff (PDF)

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer

International journal of cancer, 2019-04, Vol.144 (7), p.1676-1684

2019

Volltextzugriff (PDF)

Impact of the U.S. Preventive Services Task Force Recommendations against Prostate Specific Antigen Screening on Prostate Biopsy and Cancer Detection Rates

The Journal of urology, 2015-05, Vol.193 (5), p.1519-1524

2015

Volltextzugriff (PDF)

Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?

PloS one, 2019-04, Vol.14 (4), p.e0216255-e0216255

2019

Volltextzugriff (PDF)

Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer

European urology, 2011-09, Vol.60 (3), p.484-492

2011

Volltextzugriff (PDF)

Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse

Nature communications, 2021-10, Vol.12 (1), p.6248-15, Article 6248

2021

Volltextzugriff (PDF)

Carcinoma In Situ (CIS): Is There a Difference in Efficacy between Various BCG Strains? A Comprehensive Review of the Literature

Cancers, 2024-01, Vol.16 (2), p.245

2024

Volltextzugriff (PDF)

Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening: Against increasing PSA threshold to 10 ng/ml

European urology, 2020-12, Vol.78 (6), p.927-929

2020

Volltextzugriff (PDF)

Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort

European urology, 2015-01, Vol.67 (1), p.64-70

2015

Volltextzugriff (PDF)

Re: Management, Surveillance Patterns, and Costs Associated with Low-grade Papillary Stage Ta Non–muscle-invasive Bladder Cancer Among Older Adults, 2004–2013

European urology, 2023-01, Vol.83 (1), p.92-93

Zlotta, Alexandre R.

2023

Volltextzugriff (PDF)

Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study

PloS one, 2021-12, Vol.16 (12), p.e0259272-e0259272

2021

Volltextzugriff (PDF)

Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis

Scandinavian journal of urology, 2023-11, Vol.57 (1-6), p.29-35

2023

Volltextzugriff (PDF)

A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage

European urology, 2012-02, Vol.61 (2), p.378-384

2012

Volltextzugriff (PDF)

Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer

Radiation oncology (London, England), 2023-09, Vol.18 (1), p.1-154, Article 154

2023

Volltextzugriff (PDF)

Novel use of an old compound? Urologist‐led Bacille Calmette–Guérin vaccine trials in the prevention of coronavirus disease 2019

BJU international, 2021-01, Vol.127 (1), p.35-36

Zlotta, Alexandre R.

2021

Volltextzugriff (PDF)

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness

Modern pathology, 2007-04, Vol.20 (4), p.445-459

2007

Volltextzugriff (PDF)

Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes

European urology, 2016-02, Vol.69 (2), p.300-310

2016

Volltextzugriff (PDF)

Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer

European urology, 2012-12, Vol.62 (6), p.1088-1096

2012

Volltextzugriff (PDF)

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

Clinical epigenetics, 2019-03, Vol.11 (1), p.54-19, Article 54

2019

Volltextzugriff (PDF)

Treatment of bladder cancer in the elderly

Investigative and Clinical Urology, 2016, 57(0), , pp.26-35

2016

Volltextzugriff (PDF)

1 – 25 von 357

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(336)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(210)
Life Sciences & Biomedicine
(203)
Humans
(163)
Urology & Nephrology
(158)
Male
(124)
Urology
(90)
Aged
(83)
Biological And Medical Sciences
(71)
Medical Sciences
(71)
Middle Aged
(69)
Nephrology. Urinary Tract Diseases
(55)
Bladder Cancer
(53)
Tumors Of The Urinary System
(51)
Oncology
(50)
Urinary Tract. Prostate Gland
(49)
Urinary Bladder Neoplasms - Pathology
(46)
Female
(45)
Prostate Cancer
(40)
Prognosis
(36)
Aged, 80 And Over
(35)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic

The use of intravesical BCG in urothelial carcinoma of the bladder

Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review

Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer

Impact of the U.S. Preventive Services Task Force Recommendations against Prostate Specific Antigen Screening on Prostate Biopsy and Cancer Detection Rates

Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?

Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer

Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse

Carcinoma In Situ (CIS): Is There a Difference in Efficacy between Various BCG Strains? A Comprehensive Review of the Literature

Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening: Against increasing PSA threshold to 10 ng/ml

Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort

Re: Management, Surveillance Patterns, and Costs Associated with Low-grade Papillary Stage Ta Non–muscle-invasive Bladder Cancer Among Older Adults, 2004–2013

Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study

Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis

A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage

Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer

Novel use of an old compound? Urologist‐led Bacille Calmette–Guérin vaccine trials in the prevention of coronavirus disease 2019

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness

Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes

Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

Treatment of bladder cancer in the elderly

Suchergebnisse filtern